Suppr超能文献

症状性孤立性颈内动脉闭塞初始药物治疗:一项单中心队列研究。

Symptomatic isolated internal carotid artery occlusion with initial medical management: a monocentric cohort.

机构信息

Department of Neurology, CHRU Gui de Chauliac, 80 Avenue Augustin Fliche, 34295, Montpellier, France.

Department of Neuroradiology, CHRU Gui de Chauliac, Montpellier, France.

出版信息

J Neurol. 2021 Jan;268(1):346-355. doi: 10.1007/s00415-020-10118-9. Epub 2020 Aug 18.

Abstract

BACKGROUND

Symptomatic isolated carotid artery occlusions (ICAO) can lead to disability, recurrent stroke, and mortality, but natural history and best therapeutic management remain poorly known. The objective of this study was to describe our cohort of ICAO patients with an initial medical management.

METHODS

We conducted a retrospective study including consecutive patients admitted to our Comprehensive Stroke Center for ICAO within 24 h after stroke onset between January 2016 and September 2018. Patients with immediate endovascular therapy (EVT) were excluded. Medical treatment was based on anticoagulation (delayed by 24 h if intravenous thrombolysis was performed). 'Rescue' EVT was considered if first-week neurological deterioration (FWND) occurred.

RESULTS

Fifty-six patients were included, with a median National Institutes of Health Stroke Scale (NIHSS) of 3. Eleven patients (20%) had FWND during the first week, four benefited from rescue EVT. A mismatch volume > 40 cc on initial perfusion imaging and FLAIR vascular hyperintensities were associated with FWND (p = 0.007 and p = 0.009, respectively). Thirty-eight patients (69%) had a good outcome (modified Rankin Scale mRS 0-2) at 3 months, 36 (69%) had an excellent outcome (mRS 0-1). Seventeen patients (38%) had carotid patency on 3-month control imaging. Recurrences occurred in six (13%) of the survivors (mean follow-up: 13.6 months).

CONCLUSION

Our results suggest that the prognosis of patients with acute ICAO was favorable with a medical strategy, albeit a substantial rate of FWND and recurrence. FWND was well predicted by a core-perfusion mismatch volume > 40 cc. Randomized controlled trials are necessary to assess the benefit of EVT in ICAO.

摘要

背景

症状性孤立性颈内动脉闭塞(ICAO)可导致残疾、复发性中风和死亡率,但自然病史和最佳治疗管理仍知之甚少。本研究的目的是描述我们的一组接受初始药物治疗的 ICAO 患者。

方法

我们进行了一项回顾性研究,纳入了 2016 年 1 月至 2018 年 9 月期间中风发病后 24 小时内因 ICAO 而入住我们综合卒中中心的连续患者。排除了立即进行血管内治疗(EVT)的患者。如果进行了静脉溶栓,则在 24 小时后开始抗凝治疗。如果在第一周出现神经功能恶化(FWND),则考虑进行“抢救”EVT。

结果

共纳入 56 例患者,平均 NIHSS 评分为 3。11 例(20%)患者在第一周内出现 FWND,4 例患者受益于抢救性 EVT。初始灌注成像上的错配体积>40cc 和 FLAIR 血管高信号与 FWND 相关(p=0.007 和 p=0.009)。3 个月时,38 例(69%)患者预后良好(改良 Rankin 量表 mRS 0-2),36 例(69%)患者预后极佳(mRS 0-1)。3 个月时控制成像显示 17 例(38%)患者颈内动脉通畅。幸存者中有 6 例(13%)发生复发(平均随访 13.6 个月)。

结论

我们的研究结果表明,急性 ICAO 患者采用药物治疗策略预后良好,但 FWND 和复发的发生率较高。FWND 可通过核心灌注错配体积>40cc 进行很好的预测。需要进行随机对照试验来评估 EVT 在 ICAO 中的获益。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验